Eagle Health Investments LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eagle Health Investments LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$8,615,000
-20.9%
170,5510.0%2.01%
-25.1%
Q1 2022$10,895,000
-47.2%
170,551
-11.5%
2.68%
-46.6%
Q4 2021$20,634,000
+13.9%
192,639
+9.3%
5.03%
-12.5%
Q3 2021$18,113,000
+46.3%
176,175
+25.2%
5.74%
+35.2%
Q2 2021$12,382,000
-4.4%
140,763
+5.7%
4.25%
-16.4%
Q1 2021$12,947,000
+86.0%
133,163
+114.6%
5.08%
+14.2%
Q4 2020$6,960,00062,0604.45%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders